Mean baseline HbA1c was 7.83% and 7.80%, and baseline BMI was broadly comparable across included trials, with mean values of approximately 33.3 kg/m 2 for semaglutide and 33.6 kg/m 2 for tirzepatide, and an overall range of approximately 31 to 36 kg/m 2
However, there has been growing concern regarding a possible association between Ozempic and a unique manifestation of facial lipodystrophy syndrome, colloquially dubbed "Ozempic Face." This article aims to provide a comprehensive analysis of the phenomenon and its implications for patients and healthcare professionals
Conditions such as diabetes mellitus, insulin resistance, high-density lipoprotein isoform alterations, fatty acid elongation enzyme activity, and metabolic syndrome have been associated with migraine
Cruelty-free Products
It is important to let your eye doctor know you are taking semaglutide, especially if you have diabetic retinopathy